openPR Logo
Press release

COPD and Asthma Devices Market Booming by Size, Revenue and Trend in 2022.

04-18-2019 04:40 PM CET | Health & Medicine

Press release from: Allied Market Research

COPD and Asthma Devices Market Booming by Size, Revenue and Trend

Global COPD and asthma devices market is expected to reach $41,355.2 million by 2022, according to a new report by Allied Market Research. The drug powder inhaler was the highest revenue-generating segment, accounting for over half of the share in 2015. This segment is expected to maintain its dominance throughout the forecast period.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/579?utm_source=openpr&utm_medium=Niranjan

The factors hampering the market growth include environmental concerns associated with metered dose inhalers (MDI) and the high cost of selected inhalation devices. Regulatory authorities such as U.S. food and drug administration (USFDA) across several regions have banned the production and sales of MDIs, as they release environmentally hazardous gases such as chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA). Thus, soft mist inhalers (SMIs) and nebulizers are expected to replace MDIs for the treatment of respiratory diseases in the near future.

Compressor nebulizers constitute around the four-fifths share of the overall nebulizers market, owing to their perpetual usage in home healthcare medication and widespread availability across various regions. Nebulizers are electric- or battery-powered machines, which dispense the medication in the form of fine mist. They are used in home healthcare set-ups for debilitated patients, geriatric, and children. However, the large size of nebulizers and the need for continuous power supply are expected to hinder the market growth.

Key findings of COPD and Asthma Devices Market:
Drug powder inhalers (DPIs) segment is projected to grow at a significant CAGR of 5.7% during the forecast period.
North America was the leading region in 2015 and is expected to continue its dominance throughout the analysis period.
The COPD and asthma devices market in Europe is projected to grow at a CAGR of 6.1%.

Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/579?utm_source=openpr&utm_medium=Niranjan

The compressor nebulizers segment is expected to register a CAGR of 5.4%.
North America is expected to remain the highest revenue-generating region, owing to widespread and early adoption of inhalers & nebulizers and a large pool of patients suffering from respiratory diseases. Moreover, the Asia-Pacific region is expected to grow rapidly due to rising healthcare expenditure, growing awareness of advanced portable COPD & asthma devices, and increasing disposable income.

The key product manufacturing companies profiled in this report include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products, Inc., Sunovion Pharmaceuticals, Inc., GF Healthcare Products, Smith Medicals, Inc., Lincare Holdings, Inc., and Baxter International.

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COPD and Asthma Devices Market Booming by Size, Revenue and Trend in 2022. here

News-ID: 1709834 • Views: 313

More Releases from Allied Market Research

Home Care Monitoring and Diagnostics Market to See Extensive Worldwide Growth
Global Home Care Monitoring and Diagnostics Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Home Care Monitoring and Diagnostics Market by Product
Neuropeptide Y Receptor Market to Obtain Awesome Hike in Revenues
Global Neuropeptide Y Receptor Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, “Neuropeptide Y Receptor Market by Product (Food Grade and Pharmaceutical
Infused Dried Fruits Market Size is Set for Rapid Growth and Industry Trend by 2 …
Infused dried fruits are infused with fruit sugar solution through osmotic pressure and dried at 60°C temperature. These fruits have low calories and have low added sugar. The infused dried fruit companies have to follow standards like HACCP, BRC, IFS, and ISO22000. The infused dried fruits are vegan products that have high vitamin C, and are gluten and GMO-free. These products are also suitable for diabetics because they do not
Plant-based Food Market Growing Demand, Production Scope and Revenue 2020 to 202 …
Plant-based food refers to the food products derived from plant sources, which include fruits, vegetables, whole grains, tofu, seeds, beans, lentils, and soy. Unlike a few years ago, plant-based foods are now available conveniently in most grocery stores. The plant-based foods niche market has grown into a completely mainstream industry, since the dominant meat consumers are have shifted their preference toward plant-based meat and dairy alternatives. Download Sample Report with

All 5 Releases


More Releases for COPD

COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Asthma and COPD Drugs Market worth $50,359 Million by 2022
"The key players of the Global COPD and asthma drugs market are employing novel concepts and ideas to improve, manage and control asthma & COPD, and also enhance their profitability so as to gain a competitive edge over the other market players. Seretide/Advair, Symbicort, and Singular were leading brands and accounted for around one-fourth share in world COPD and asthma drugs market." Global Asthma and COPD Drugs Market was valued at
Alarming Prevalence of COPD to Propel Oxygen Therapy Devices Market
"Oxygen therapy equipment market driven by increasing urbanization and rising levels of air pollution." An intelligence report on the global oxygen therapy equipment market has been added to the burgeoning portfolio of MarketResearchReports.biz. Titled, “Global Oxygen Therapy Equipment Market - Analysis By Product, Portability, Application, Region, Country: Opportunities and Forecast (2017- 2022) - By Product (Oxygen Concentrators, Liquid Oxygen Devices and Oxygen Cylinders), By Portability (Stationary, Portable Devices), By Application (COPD,
Asthma and COPD Drugs Market | Key Opportunities And Forecast 2024
The top five companies in the U.S. and China Asthma And Copd Drugs Market accounted for just under 64.0% in 2015, hinting at not just the consolidated nature of this industry but also at the immense competition among players. GlaxoSmithKline plc, Astrazeneca plc, Boehringer Ingelheim, Merck & Co. Inc., and Novartis AG currently enjoy the leading spots in the asthma and COPD drugs market. According to Transparency Market Research, the opportunity
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the